1212 EXPOSURE-RESPONSE ANALYSES OF PEGYLATED INTERFERON LAMBDA (LAMBDA, BMS-914143) IN PATIENTS WITH CHRONIC HCV INFECTION: DOSE SELECTION FOR PHASE 3 CLINICAL TRIALS

✍ Scribed by Wang, X.; Chan, P.; Ahmad, A.; Freeman, J.; Horga, A.; Hillson, J.; Lopez-Talavera, J.C.; Kansra, V.

• Book ID: 121823055
• Publisher: Elsevier Science
• Year: 2012
• Tongue: English
• Weight: 64 KB
• Volume: 56
• Category: Article
• ISSN: 0168-8278
• DOI: 10.1016/S0168-8278(12)61224-0